medigraphic.com

2012, Número 3

<< Anterior Siguiente >>

Rev Cuba Endoc 2012; 23 (3)


Enfoque terapéutico de algunas enfermedades del tiroides en Pediatría

Pérez GC

Idioma: Español
Referencias bibliográficas: 57
Paginas:
Archivo PDF: 210.71 Kb.


RESUMEN

Las enfermedades del tiroides ocupan un lugar importante, por su frecuencia y variedad, entre las afecciones endocrinas del niño y el adolescente, y aunque puedan padecer las mismas enfermedades tiroideas del adulto, presentan afecciones específicas de la edad, cuyo diagnóstico y tratamiento adecuado puede prevenir los efectos devastadores e irreversibles que estas pueden producir. Se presenta, con interés de actualizar y establecer consenso, el enfoque terapéutico de algunas tiroidopatías de la infancia, en orden de importancia y frecuencia, como es el nódulo de tiroides, el bocio y el hipertiroidismo.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Guell R. Prólogo. En: Permanyer Publications. Enfermedades del tiroides en niños y adolescentes. Barcelona: Permanyer Publications; 1998. p. 1-2.

  2. Morten JD, Woolner LB, Bennet WA. Gross and microscopic findings in clinically hormonal thyroid glands. J Clin Endocrinol Metab. 1955;15:1270-80.

  3. Salas M. Nódulos tiroideos. Cáncer de tiroides. En: Pombo M. editor. Tratado de Endocrinología Pediátrica. 3ra. ed. Madrid: Mc Graw-Hill; 2002. p. 584-99.

  4. Muñoz MT, Argente J. Nódulo tiroideo y carcinoma de tiroides. En: Argente J, editor. Tratado de Endocrinología Pediátrica. 2da. edición. Barcelona: Doyma;1994. p. 539-48.

  5. Scott MD, Crawford JD. Solitary thyroid nodules in childhood: is the incidence of thyroid carcinoma declining? Pediatrics. 1976;58:85-90.

  6. Richard M. Familial Thyroid cancer syndrome. Thyroid. 2010;7(7):231-8.

  7. Sipos JA. Advances in ultrasound for the diagnosis and management of thyroid cancer. Thyroid. 2009;19(12):123-30.

  8. Fassina AS, Rupolo M, Pelizzo MR. Thyroid cancer in children and adolescents. Tumori. 1994;80:257-62.

  9. Gharib H. Changing concepts in the diagnosis and management of thyroid nodules. Endocrinol Metab Clin North Am. 1997;26:237-8.

  10. Gharib H, Papini E, Paschke R, Duick DS, Valkavi R, Hegedus R, Vitti P, AACE/AME/ETA Task Force on Thyroid Nodules American Association of Clinical Endocrinologists, Associazione Medici Endocrinoli and European Thyroid Association Medical Guidelines for clinical practices for the diagnosis and management of the thyroid nodules. Endocr Pract. 2010;16:468-75.

  11. Ares Segura S, Quero Jiménez J, Morreale de Escobar G. Enfermedades frecuentes del tiroides en la infancia. Rev Pediatr Atenc Primaria. 2009;11 Supl16:173-s204.

  12. Salas M. Thyroid Nodules in children and adolescent. En: Fima Lifshitz. Clinical Pediatrics/8. A Clinical Guide. Pediatric Endocrinology. 1996;29:415-20.

  13. Rosario PW, Santos D, Bessa B. Nodular Thyroid Disease. Natural history of nodules without an initial indication for the cytology. The Endocrinologist. 2010;20:243-4.

  14. Hermoso F, Nieto JA, Pastor JA, Rivas F. Bocio y nódulo tiroideo. Sociedad Española de Endocrinología Pediátrica. Cap 16. Madrid: Ed Díaz de Santos; 2010. p. 3-14.

  15. Ardas IS, Yilfrim S, Demirhan B, Firat S. Fine needle aspiration biopsy of thyroid nodules. Arc Dis Child. 2001;85(4):313-7.

  16. Ross DS. Diagnostic approach to and treatment of thyroid nodules. The Endocrine Society. Up to Date in Endocrinology and Diabetes. Thyroid Guidelines in Endocrine Practices. May/Jun 2010;16 (suppl 1):4.

  17. Muñoz MT, Argente J. Nodulo Tiroideo y Carcinoma de Tiroides. En: Argente J. Tratado de Endocrinologia Pediátrica. Barcelona: Doyma; 1994. p. 33, 539-48.

  18. Mc Caffrey TV. Evaluation of the Thyroid Nodule. Cancer Control. 2000;7:223-8.

  19. Gharib H, James EM, Charboneau JW, Naessens JM, Offord KP, Gorman CA. Suppressive therapy with Lev LaFranchi S, Ana CE. Graves Disease in the neonatal period and childhood. The Thyroid: a fundamental and clinical textbook. 8va. ed. Braverman LE, Utiger RD, eds. Philadelphia: Lippincott Williams and Wilkins; 2000. p. 983-97.

  20. López- Siguero JP, Moreno Molina JA, Martínez García MA. Cáncer de tiroides en la infancia. En: Pombo Areas M. Tratado de Endocrinología Pediátrica. 3ra. ed. Madrid: Ed. Mc Graw-Hill Interamericana; 2002. p. 35,584-99.

  21. Hung W. Nodular thyroid disease and thyroid carcinoma. Pediatr Ann. 1992;21:50-7.

  22. Attie JN. Carcinoma of the thyroid in children and adolescent. En: En: Clinical Pediatrics/8. A Clinical Guide. Edited by Fima Lifshitz. Pediatric Endocrinology. 1996;29:415-20.

  23. Garib H, Goellner JR. Fine needle aspiration biopsy of the thyroid: An appraisal. Ann Int Med. 1993;118:282-9.

  24. Tae Hyuk K, Jung Ah L, Hwa Young A, Eun Kyung L, Hye Sook M, Kium Yun-Hee C, et al. Tumor size and age predict the risk of malignancy in Húrthle Cell neoplasm the thyroid and can therefore guide the extent of initial thyroid surgery. Thyroid. 2010;20(11):568-76.

  25. American Thyroid Association (ATA), Guidelines Taskforce of Thyroid Nodules and Differentiated Cancer, Cooper DS, Doherty DM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167-214.

  26. López-Siguero JP, Moreno Molina JA, Martínez García MA. Bocios. Deficiencia de yodo. En: Pombo Áreas M. 3ra. ed. Tratado de Endocrinología Pediátrica. Madrid: Ed. Mc Graw-Hill Interamericana; 2002. p. 34,570-83.

  27. Dallas JS, Thomas P, Foley Jr. Thyromegaly En: En: Clinical Pediatrics/8. A Clinical Guide. Edited by Fima Lifshitz. Pediatric Endocrinology. 1996;26:383-7.

  28. Botero D. Tiroiditis de la infancia. En: Pombo Áreas M. 3ra. ed. Tratado de Endocrinología Pediátrica. Madrid: Ed. Mc Graw-Hill Interamericana; 2002. p. 33,565-9.

  29. Sandrini R, Nesi S, DE Lacerda L. Hipertiroidismo. En: Tratado de Endocrinología Pediátrica. En: Pombo Áreas M. 3ra. ed. Madrid: Ed. Mc Graw-Hill Interamericana; 2002. p. 32,557-64.

  30. Iglesias Fernández C, Rodríguez Arnao MD. Hipertiroidismo. Protoc diagn ter pediatr. 2011;1:129-40.

  31. Andrew J Bauer. Approach to the Pediatric Patient with Graves' Disease: When is Definitive Therapy Warranted? J Clin Endocrinol Metab. March 2011;96(3):580-8.

  32. Franklyn JA, Boelaer K. Thyrotoxicosis. Lancet. 2012;379:1155-66

  33. Bahn (Chair) RS, Burch HB, Cooper DS, Garber JR, Greeniee MC, Klein I, et al. Hyperthyroidism and other cause of Thyrotoxicosis: Management and guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid. 2011;21(6):593-646.

  34. Consenso en el diagnóstico y tratamiento de las afecciones del tiroides. Rev Cubana Endocrinol. 2004;15(1):12-5.

  35. Leslie J, De Groot MD. Diagnosis and treatment of Graves' disease [monografía en Internet]. April 2010 [citado 2 de febrero de 2012]. Disponible en: http://www.thyroidmanager.org/chapter/diagnosis-and-treatment-of-graves-disease/

  36. Uricoechea Vargas H. Hipertiroidismo: enfermedad de Graves. N Engl J Med. 2008;358:2594-605.

  37. Cooper DS. Antithyroid Drugs. N Engl J Med. 2005;352:905-17.

  38. Slyper AH, Wyatt D, Boudreau C. Effective methimazole dose for childhood Graves and use of free triiodothyronine combined with concurrent thyroid stimulating hormone level to identified mild hyperthyroidism and delayed pituitary recovery. J Pediatr Endocrinol Metab. 2005;18:597-602.

  39. Andersohn F, Konzen C, Garben E. Systematic review: agranulocitosis induced by nonchemotherapy drugs. Ann Inter Med. 2007;146:657-65.

  40. Bauer AJ. Approach to the Pediatric patient with Graves´ disease: When is definitive therapy warranted? J Clin Endocrinol Metab. 2011;96(3):580-8.

  41. FDA U.S. Food and drug administration information for healthcare professionals-propyltiouracil-induced liver failure [monografía en Internet]. 2009 [citado 20 de enero de 2012]. Disponible en: http://google2.fda.gov/search?q=www.fda.govFDrugsFDruSafetyFPostmarketDrugSafetyInformationforPatientandProvidersFDrugsafetyInformationforHeathcareProfessionalsFucm160721.htm+&client=FDAgov&site=FDAgov&lr=&proxystylesheet=FD Agov&output=xml_no_dtd&getfields

  42. Read C Jr, Tansey M, Menda Y. A 36-year retrospective analisis of efficacy and safety of radioactive iodine in treating young Graves' patients. J Clin Endocrinol Metab. 2001;14:229-43.

  43. Rivkees SA, Dinauer C. An optimal treatment for pediatric Graves'disease is radioiodine. J Clin Endocrinol Metab. 2007;92:797-800.

  44. Howarths D, Eptein M, Lem L, Barca MS, Gruppi C, Oliveira MT, et al. Determination of the optimal minimum radioiodine dose to patients with Graves'disease: a clinical outcome study. Eur J Nucl Med. 2001;28:1489-95.

  45. Metso S, Auvinen A, Huhtala H, Salmi J, Otsala H, Jaatinen P. Increased cancer incidence after radioiodine treatment for hyperthyroidism. Cancer. 2007;109;1972-9.

  46. Kobe C, Eschner W, Sudbrock F, Weber I, Marx K, DietlenM, et al. Graves'disease and radioiodine therapy. Is success of ablation dependent on the achieved dose above 200 Gy? Nuklearmedizine. 2008;47:13-7.

  47. Gregory A, Brent MD. Graves'Disease. N Engl J Med. 2008;358;24:2594.

  48. Godoy C, Acevedo M, Barrera N, Anahí Yismeyián M, Ugarte F. Hipertiroidismo en niños y adolescentes. Rev Chil Pediatr. 2009;80(1):21-9.

  49. LaFranchi S, Ana CE. Graves'Disease in the neonatal period and childhood. The Thyroid: a fundamental and clinical textbook. 8va. ed. Braverman LE, Utiger RD, eds. Philadelphia: Lippincott Williams and Wilkins; 2000. p. 989-97.

  50. Ma C, Kuang A, Xie J, Liu G. Radioiodine treatment for pediatric Graves'disease. Cochrane Database Syst Rev. 2008;15(2):456-62.

  51. Boice JD Jr. Radiation induced Thyroid cancer- what's new? J Natl Cancer Inst. 2005;97:703-5.

  52. Sato H, Harada S, Yokoya S, Tanaka T, Asayama K, Mori M, Sasaki N. Treatment for childhood- onset Graves'disease in Japan: result of the nationwide questionnaire survey of pediatric endocrinologists and thyroidologists. Thyroid. 2007;17:67-72.

  53. Lee JA, Grumbach MM, Clark OH. The optimal treatment for pediatric Graves'disease is surgery. J Clin Endocrinol Metab. 2007;92:801-3.

  54. Tuggle CT, Roman SA, Wang TS, Boudourakis L, Thomas D, Udelsman N, Ann Sosa J. Pediatric endocrine surgery: who is operating on our children. Surgery. 2008;144:869-77.

  55. Mussa GC, Corrias A, Silvestro L, Battan E, Mostert M, Mussa F, et al. Factors and onset predictive of lasting remission in pediatric patient with Graves'disease followed for at least three years. J Pediatr Endocrinol Metab. 1999;12:537-41.

  56. Cassio A, Corrias A, Gualandi S, Tato L, Cesaretti G, Volta C, et al. Influence of gender and pubertal stage at diagnosis on growth outcome in childhood thyrotoxicosis: result of a collaborative study. Clin Endocrinol (Oxf). 2006;64:53-7.

  57. Smith J, Brown RS. Persistence of thyrotropin (TSH) receptor antibodies in children and adolescents with Graves'disease treated using antithyroid medication. Thyroid. 2007;17:1103-7.




2020     |     www.medigraphic.com